Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects (review)

37Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Due to the high mortality rate and unsatisfactory treatment options available, hepatocellular carcinoma (HCC) remains one of the most common malignancies and a leading cause of cancer-associated mortality. Novel therapeutic targets for HCC are urgently required. Advanced RNA sequencing technology enables the identification of considerable amounts of noncoding RNAs (ncRNAs), including small noncoding RNAs and long noncoding RNAs, which exhibit no protein-coding activities. In this respect, ncRNAs and their regulatory processes are important factors in liver tumorigenesis. The present review focuses on the characteristics and biological roles of ncRNAs in HCC. Potential therapeutic applications of ncRNAs in HCC are also evaluated.

Cite

CITATION STYLE

APA

Xiao, Z., Shen, J., Zhang, L., Li, M., Hu, W., & Cho, C. (2018, March 1). Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects (review). Oncology Letters. Spandidos Publications. https://doi.org/10.3892/ol.2018.7758

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free